NCT00020501View on ClinicalTrials.gov

Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2001

Study Completion Date

January 31, 2005

Conditions
Colorectal CancerMetastatic Cancer
Interventions
DRUG

FOLFIRI regimen

DRUG

floxuridine

DRUG

fluorouracil

DRUG

irinotecan hydrochloride

DRUG

leucovorin calcium

DRUG

melphalan

PROCEDURE

hyperthermia treatment

Trial Locations (1)

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00020501 - Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | Biotech Hunter | Biotech Hunter